Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Relypsa completes financing round to support RLY-5016 development

Sep. 23, 2010

FibroGen receives Chinese approval to begin clinical trials of FG-4592 in CKD anemia

Sep. 22, 2010

AP-214 reduces development of acute kidney injury in phase II trial

Sep. 14, 2010

Studies evaluate tamsulosin and doxazosin for urolithiasis

Sep. 6, 2010

PEARL-HF study shows reduced hyperkalemia with RLY-5016

Sep. 1, 2010

AF-792, a selective inhibitor of P2X2/3 and P2X3 receptors, regulates bladder activity in rats

Aug. 31, 2010

Recordati discloses new metabotropic glutamate mGlu5 receptor antagonists

Aug. 27, 2010

Netupitant shows promise to treat overactive bladder in preclinical studies

Aug. 27, 2010

Genz-123346 inhibits cystogenesis in models of polycystic kidney disease

Aug. 20, 2010

FDA grants Urigen Pharmaceuticals type C meeting for URG-101

Aug. 19, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...